Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Arcadia Biosciences (RKDA) Change in Intangibles (2024 - 2025)

Arcadia Biosciences' Change in Intangibles history spans 2 years, with the latest figure at $250000.0 for Q2 2025.

For Q2 2025, Change in Intangibles fell 93.75% year-over-year to $250000.0; the TTM value through Dec 2025 reached $750000.0, down 90.62%, while the annual FY2025 figure was $750000.0, 81.25% down from the prior year.
Change in Intangibles reached $250000.0 in Q2 2025 per RKDA's latest filing, down from $500000.0 in the prior quarter.
In the past five years, Change in Intangibles ranged from a high of $4.0 million in Q2 2024 to a low of $250000.0 in Q2 2025.